Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioSource International was a leading provider of functional genomics and proteomics products used in drug discovery and biomedical research. The company specialized in the development and manufacture of antibodies, ELISA kits, recombinant proteins, and multiplex assays for the detection of cytokines and signal transduction molecules. Headquartered in Camarillo, California, BioSource served academic, pharmaceutical, and biotechnology researchers worldwide. In 2005, the company was acquired by Invitrogen Corporation for approximately $130 million. Its technologies were subsequently integrated into the Life Technologies brand and eventually into Thermo Fisher Scientific. The company was particularly recognized for its expertise in phosphorylation-specific antibodies and Luminex-based multiplexing platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioSource International.